Chemo delivery method may impact sleep and depression in GI cancer patients

NCT ID NCT06996483

Completed Knowledge-focused Sponsor: Ankara Etlik City Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 198 adults with non-metastatic gastrointestinal cancer to see if taking chemotherapy as a pill (oral) or through a vein (IV) affects sleep quality and depression. Researchers measured sleep and mood before treatment, at 45 days, and at 90 days using standard questionnaires. The study did not change any treatment—it only observed and tracked these symptoms during routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression digestive system cancer digestive system neoplasm insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROINTESTINAL NEOPLASMS

Contacts and locations

Locations

Ankara Etlik City Hospital

Ankara, Yenimahalle, 06210, Turkey (Türkiye)
Etlik City Hospital

Ankara, Yenimahalle, 06210, Turkey (Türkiye)
Etlik City Hospital, Medical Oncology Department

Ankara, Yenimahalle, 06210, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.